# Renal prognostic value of serum monoclonal immunoglobulin in cryoglobulinemic glomerulonephritis

**Authors:** Lei Ma, Yuanyuan Xia, Yun Fan, Dan Zhou, Xinchen Yao, Yongzhong Zhong, Fan Yang, Feng Xu, Shaoshan Liang, Yujie Wang, Xiaodong Zhu, Dacheng Chen, Rong Tan, Zhengyun Zhu, Dandan Liang, Caihong Zeng

PMC · DOI: 10.3389/fimmu.2025.1578295 · Frontiers in Immunology · 2025-07-29

## TL;DR

This study shows that patients with cryoglobulinemic glomerulonephritis and serum monoclonal immunoglobulin have worse kidney outcomes, regardless of viral infections.

## Contribution

The study identifies serum monoclonal immunoglobulin as an independent risk factor for poor renal prognosis in Cryo-GN without autoimmune diseases.

## Key findings

- Patients with serum monoclonal immunoglobulin had lower eGFR and higher cryoglobulin levels.
- Serum monoclonal immunoglobulin and eGFR were independent prognostic factors for renal survival.
- The MIg group had worse renal survival compared to the HBV/HCV group.

## Abstract

To explore the clinicopathological features and renal outcome in patients with cryoglobulinemic glomerulonephritis (Cryo-GN) without confirmed systemic autoimmune diseases.

Sixty-nine patients with Cryo-GN from a single center were recruited in this retrospective study. Their clinical, pathologic, and follow-up data were collected and analyzed. According to whether the serum monoclonal immunoglobulin (MIg) and HBV-DNA/HBV markers or HCV-RNA/anti-HCV antibodies were positive or not, they were classified into four groups: positive serum MIg only (MIg group), positive HBV-DNA/HBV markers or HCV-RNA/anti-HCV antibodies (HBV/HCV) only (HBV/HCV group), positive serum MIg and HBV/HCV (MIg+HBV/HCV group), and all MIg/HBV/HCV negative group.

The male-to-female ratio was 1.38:1 with a mean age of 50.4 ± 14.7 years in the patient cohort. Hypertension was presented in 59.4% of cases, anemia in 73.9%, renal insufficiency in 60.9%, nephrotic proteinuria in 44.9% and microscopic hematuria in 94.2%. The MIg group had significantly lower eGFR levels, higher cryoglobulin levels, and higher rates of abnormal serum-free light chain ratios than the MIg/HBV/HCV negative group. The most common histological pattern of Cryo-GN was membranoproliferative glomerulonephritis (MPGN), and the MIg group had significantly higher scores of the severity of intracapillary cryo-Plugs than the MIg+HBV/HCV group and the MIg/HBV/HCV negative group. Immunohistochemical staining of 29 patients revealed a significant infiltration of CD68+ cells within the glomeruli. Further multiplex immunohistochemical staining of 4 of these patients showed that the infiltrating cells within the glomeruli in Cryo-GN were predominantly CD68+CD163+ cells. Sixty-seven patients had a median follow-up of 31.7 months, and 23.9% of them progressed to end-stage renal disease (ESRD). The renal survival was inferior for MIg group than HBV/HCV group. Multivariate analysis showed that serum MIg and eGFR were independent prognostic factors.

Regardless of the presence of HBV/HCV infection, non-systemic autoimmune diseases related Cryo-GN patients with serum MIg had worse renal function and renal survival. Patients with a large number of pseudothrombi in the glomerular capillary lumens tend to have worse renal outcomes. Serum MIg and eGFR were independent risk factors for renal survival in Cryo-GN patients without autoimmune diseases.

Renal prognostic value of serum monoclonal immunoglobulin in cryoglobulinemic glomerulonephritis is shown. Sixty-nine patients are divided into four groups, with a median follow-up of 31.7 months. Baseline characteristics include age, serum creatinine, renal insufficiency, urine protein, cryoglobulin concentration, and others. Images of macrophages with CD68/CD163 and CD68/CD86 markers are displayed. Kaplan-Meier curves illustrate renal survival. The conclusion states that non-systemic autoimmune diseases related Cryo-GN patients with serum Mlg had worse renal function and survival, regardless of HBV/HCV infection presence. Time frame is 2003-2024.

## Linked entities

- **Proteins:** CD68 (CD68 molecule), CD163 (CD163 molecule), CD86 (CD86 molecule)
- **Diseases:** end-stage renal disease (MONDO:0004375), anemia (MONDO:0002280), renal insufficiency (MONDO:0001106)

## Full-text entities

- **Genes:** CD68 (CD68 molecule) [NCBI Gene 968] {aka GP110, LAMP4, SCARD1}, CD163 (CD163 molecule) [NCBI Gene 9332] {aka M130, MM130, SCARI1}
- **Diseases:** Hypertension (MESH:D006973), hematuria (MESH:D006417), MPGN (MESH:D015432), autoimmune diseases (MESH:D001327), Cryo-GN (MESH:D005921), HBV/HCV infection (MESH:D006509), nephrotic proteinuria (MESH:D011507), anemia (MESH:D000740), systemic (MESH:D015619), renal insufficiency (MESH:D051437), ESRD (MESH:D007676)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12339349/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12339349/full.md

## References

51 references — full list in the complete paper: https://tomesphere.com/paper/PMC12339349/full.md

---
Source: https://tomesphere.com/paper/PMC12339349